首页> 美国卫生研究院文献>Frontiers in Integrative Neuroscience >Acupuncture Treatment Reverses Retinal Gene Expression Induced by Optic Nerve Injury via RNA Sequencing Analysis
【2h】

Acupuncture Treatment Reverses Retinal Gene Expression Induced by Optic Nerve Injury via RNA Sequencing Analysis

机译:针刺治疗通过RNA序列分析逆转视神经损伤诱导的视网膜基因表达

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Glaucoma and traumatic optic nerve crush (ONC) injury result in progressive loss of retinal ganglion cells (RGCs) and defects in visual function. In clinical trials of Traditional Chinese Medicine, acupuncture has been widely used for the treatment of ocular diseases. However, the molecular mechanisms of acupuncture treatment are still unclear. In this study, we used technique of RNA sequencing (RNA-seq) to study the effects of acupuncture treatment on retinal transcriptome after axotomy injury. RNA-seq results revealed that 436 genes including 31 transcription factors (TFs) were changed after injury, among them were many well-known neural degeneration related TFs such as Jun, Ddit3, Atf3, and Atf4. Interestingly, acupuncture treatment at acupoint GB20 (Fengchi) significantly reversed a series of differential expressed genes (DEGs) induced by optic nerve injury. While treatments at BL1 (Jingming) or GB20 sham control acupoint-GV16 (Fengfu), led to limited DEG reversal. In contrast, treatments at these two sites further enhanced the trend of DEG expression induced by axotomy injury. At last, retina immunostaining results revealed that only GB20 acupoint treatment increased RGC survival, in consistent with RNA-seq results. Therefore, our study first reported that acupuncture treatment regulated retinal transcriptome and reversed the gene expression induced by axotomy injury, and GB20 acupoint treatment increased RGC survival, which will provide novel therapeutic targets for treatment of ocular diseases.
机译:青光眼和外伤性视神经挤压伤(ONC)导致视网膜神经节细胞(RGC)逐渐丧失和视觉功能缺陷。在中医药的临床试验中,针灸已被广泛用于治疗眼部疾病。但是,针灸治疗的分子机制仍不清楚。在这项研究中,我们使用RNA测序技术(RNA-seq)来研究针刺治疗对轴突切开术后视网膜转录组的影响。 RNA-seq结果显示,包括31个转录因子(TFs)在内的436个基因在受伤后发生了变化,其中包括许多与神经变性相关的TFs,例如Jun,Ddit3,Atf3和Atf4。有趣的是,在GB20穴位(凤池)进行针灸治疗可显着逆转视神经损伤诱导的一系列差异表达基因(DEG)。 BL1(京明)或GB20假手术的治疗控制穴位GV16(Fengfu),导致有限的DEG逆转。相反,在这两个部位的治疗进一步增强了由轴切术损伤诱导的DEG表达的趋势。最后,视网膜免疫染色结果显示只有GB20穴位治疗可增加RGC存活率,与RNA-seq结果一致。因此,我们的研究首先报道了针刺治疗可调节视网膜转录组并逆转由轴切术所致的基因表达,而GB20穴位治疗可增加RGC的存活率,这将为眼部疾病的治疗提供新的治疗靶点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号